Karen Massey is the Chief Operating Officer at argenx, bringing extensive experience from her tenure at Genentech, where she focused on product development and global clinical operations. She is passionate about reimagining healthcare delivery and creating purpose-driven organizations. Karen earned her MBA from NYU Stern School of Business.
Outside of her professional life, Karen is committed to driving innovation to help patients and advocating for disease awareness. She actively supports initiatives that raise understanding for conditions like Myasthenia Gravis.
Karen is nominated by the Board of Directors as the next CEO of argenx.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.